FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Long Term Debt 2020–2025
FibroGen, Inc. annual long term debt history from 2020 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- FibroGen, Inc. long term debt as of December 31, 2024: 73.1M, a 47.21% decrease year-over-year.
- FibroGen, Inc. long term debt for 2024 were 73.1M, a 47.21% decrease from 2023.
- FibroGen, Inc. long term debt for 2023 were 138.5M, a 73.97% increase from 2022.
- FibroGen, Inc. long term debt for 2022 were 79.6M, a 10.34% decrease from 2021.
- FibroGen, Inc. long term debt for 2021 were 88.8M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| FibroGen, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $73 |
| 2023 | $138 |
| 2022 | $80 |
| 2021 | $89 |
| 2020 | $26 |
FibroGen, Inc. Long Term Debt — FAQ
FibroGen, Inc. (KYNB) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's long term debt history?
The chart and table above show FibroGen, Inc.'s long term debt by year and by quarter, including the growth rate.